GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Purchase Of Investment

Allied Biotech (ROCO:1780) Purchase Of Investment : NT$-17.8 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Allied Biotech Purchase Of Investment?

Allied Biotech's purchase of investment for the six months ended in Dec. 2023 was NT$0.0 Mil. It means Allied Biotech spent NT$0.0 Mil on purchasing investments. Allied Biotech's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-17.8 Mil.

Compared with last quarter (NT$-17.8 Mil in Jun. 2023 ), Allied Biotech spent less money on purchasing investments in Dec. 2023 (NT$0.0 Mil).

Allied Biotech Purchase Of Investment Historical Data

The historical data trend for Allied Biotech's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Biotech Purchase Of Investment Chart

Allied Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.08 - -130.95 - -

Allied Biotech Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.52 - - -17.82 -

Allied Biotech Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-17.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allied Biotech Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Allied Biotech's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Allied Biotech (ROCO:1780) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Purchase Of Investment
Comparable Companies
ROCO:6817 TPE:3054 ROCO:4117 ROCO:6496 ROCO:8432 ROCO:6935 ROCO:4172 ROCO:7561 ROCO:4127 ROCO:6677 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Website
http://www.altratene.com
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.

Allied Biotech (ROCO:1780) Headlines

No Headlines